PTPS-14 THE NEED FOR MULTI-TARGETED THERAPY IN PEDIATRIC BRAIN TUMORS WITH BRAF MUTATION

類似資料

• IMCT-22 PHASE I STUDY OF FOURTH VENTRICLE INFUSIONS OF AUTOLOGOUS EX VIVO EXPANDED NK CELLS IN CHILDREN WITH RECURRENT/REFRACTORY POSTERIOR FOSSA TUMORS OF THE CENTRAL NERVOUS SYSTEM
  著者:: Zaky, Wafik, 等
  出版事項: (2015)
• PTCT-05 CHEMOTHERAPY ADMINISTRATION DIRECTLY INTO THE FOURTH VENTRICLE IN CHILDREN WITH MALIGNANT FOURTH VENTRICULAR BRAIN TUMORS: A PILOT CLINICAL TRIAL
  著者:: Sandberg, David I., 等
  出版事項: (2015)
• EPT-17 PHASE I STUDY OF BRAF INHIBITOR (VEMURAFENIB) IN COMBINATION WITH THE MTOR INHIBITOR (EVEROLIMUS) IN BRAF(V600E) POSITIVE CHILDHOOD AND AYA BRAIN TUMORS
  著者:: Tanaka, Ryuma, 等
  出版事項: (2016)
• PTPS-13 STUDY OF CLINICOPATHOLOGICAL CHARACTERISTICS, BRAF V600E MUTATION, AND MTOR SIGNALING PATHWAY ACTIVATION IN DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS (DNET)
  著者:: Kakkar, Aanchal, 等
  出版事項: (2015)
• PTPS-02 FOXR2: AN ONCOGENE IN MEDULLOBLASTOMA
  著者:: Das, Paramita, 等
  出版事項: (2015)